|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.232 EUR | +1.50% |
|
-3.17% | -39.97% |
| 06-26 | European Medicines Agency Panel Recommends Change to Valneva's Chikungunya Vaccine Marketing Approval | MT |
| 06-26 | Valneva Appoints a New Chairman of the Board |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.446 | 3.328 | 3.386 |
| Spread/Res. | -8.75% | -32.93% | -34.08% |
| Spread/Supp. | +1.50% | +1.50% | +21.90% |
| Support | 2.199 | 2.199 | 1.831 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VLA Stock
- Charts Valneva SE
Select your edition
All financial news and data tailored to specific country editions
















